{"_meta":{"attribution":"Data aggregated by pdata.world (https://pdata.world) from Polymarket, Kalshi, Manifold, Myriad, Limitless, Predict, Opinion and Gemini; CC BY 4.0; source data © each venue.","canonical_url":"https://pdata.world/events/kalshi/KXFDAANNOUNCE-BPC","as_of":"2026-11-20T02:00:40.028290Z","docs":"https://api.pdata.world/docs","cite_as":"According to pdata.world (tracking Kalshi): \"When will the FDA reclassify BPC-157 to Category 1?\" — 6 markets; highest \"Before 2027\" at 8% as of 2026-11-20 UTC. https://pdata.world/events/kalshi/KXFDAANNOUNCE-BPC","source_url":"https://kalshi.com/markets/kxfdaannounce/when-will-the-fda-reclassify-bpc-157-to-category-1/kxfdaannounce-bpc","data_as_of":"2026-11-20T01:35:37.938813Z","full_record":"https://api.pdata.world/api/v1/events/kalshi/KXFDAANNOUNCE-BPC","price_history":"https://api.pdata.world/api/v1/events/kalshi/KXFDAANNOUNCE-BPC/history?range=7d&limit=20"},"kind":"live","venue":"Kalshi","source":"kalshi","id":"KXFDAANNOUNCE-BPC","title":"When will the FDA reclassify BPC-157 to Category 1?","status":"open","categories":["Science and Technology"],"countries":["United States"],"closes_at":"2027-01-01T15:00:00Z","outcomes_are":"independent markets, each resolving on its own","volume_24h":1046.24,"volume_total":77053.83,"volume_unit":"contracts, as Kalshi reports them","outcomes_total":6,"outcomes":[{"name":"Before 2027","probability":0.08,"change_24h":0.02,"volume_24h":1046.24,"market_id":"KXFDAANNOUNCE-BPC-27JAN01"},{"name":"Before April 15","probability":0.02,"volume_24h":0.0,"result":"no","market_id":"KXFDAANNOUNCE-BPC-26APR15"},{"name":"Before September","probability":0.02,"volume_24h":0.0,"result":"no","market_id":"KXFDAANNOUNCE-BPC-26SEP01"},{"name":"Before July","probability":0.01,"volume_24h":0.0,"result":"no","market_id":"KXFDAANNOUNCE-BPC-26JUL01"},{"name":"Before May","probability":0.01,"volume_24h":0.0,"result":"no","market_id":"KXFDAANNOUNCE-BPC-26MAY01"},{"name":"Before November","probability":0.01,"volume_24h":0.0,"result":"no","market_id":"KXFDAANNOUNCE-BPC-26NOV01"}],"rules":"If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes.\n\n---\n\nThe Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. \nRemoval from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.","rules_apply_to":"the first outcome listed; each other outcome has its own text, in the full record"}